We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
4 result(s) found, displaying 1 to 4
-
Australian public assessment report (AusPar)Nexobrid (anacaulase-bcdb) has been approved for eschar removal in adults and paediatric patients with deep partial thickness and/or full thickness thermal burns.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NEXOBRID anacaulase-bcdb 4.85 g powder vial with diluent gel bottle composite pack.
-
Prescription medicine registrationActive ingredients: anacaulase-bcdb.
-